Screener
Maze Therapeutics MAZE Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Maze Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's debt-to-equity?
- Maze Therapeutics (MAZE) reported debt-to-equity of 0.1× in Q2 2026.
- How has Maze Therapeutics's debt-to-equity changed year-over-year?
- Maze Therapeutics's debt-to-equity increased by 39.7% year-over-year, from 0.1× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Maze Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude